Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Net Income towards Common Stockholders: 2017-2025

Historic Net Income towards Common Stockholders for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $14.5 million.

  • Organogenesis Holdings' Net Income towards Common Stockholders rose 17.79% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.4 million, marking a year-over-year decrease of 81.48%. This contributed to the annual value of -$937,000 for FY2024, which is 118.95% down from last year.
  • Organogenesis Holdings' Net Income towards Common Stockholders amounted to $14.5 million in Q3 2025, which was up 219.04% from -$12.2 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Net Income towards Common Stockholders ranged from a high of $51.0 million in Q4 2021 and a low of -$21.6 million during Q1 2025.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$568,000 (2023), whereas its average is -$1.4 million.
  • In the last 5 years, Organogenesis Holdings' Net Income towards Common Stockholders soared by 1,373.02% in 2023 and then plummeted by 928.14% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Net Income towards Common Stockholders (Quarterly) stood at $51.0 million in 2021, then crashed by 85.32% to $7.5 million in 2022, then crashed by 107.59% to -$568,000 in 2023, then surged by 1,134.33% to $5.9 million in 2024, then increased by 17.79% to $14.5 million in 2025.
  • Its Net Income towards Common Stockholders stands at $14.5 million for Q3 2025, versus -$12.2 million for Q2 2025 and -$21.6 million for Q1 2025.